Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis

Publisher： Karger

E-ISSN： 1421-9751|130|2|96-105

ISSN： 0008-6312

Source： Cardiology, Vol.130, Iss.2, 2015-01, pp. : 96-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcome of DES versus BMS

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 203-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐eluting stents versus bare metal stents prior to noncardiac surgery

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 533-541

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir‐based polymer‐free amphilimus‐eluting stents versus everolimus‐eluting stents with durable polymer in patients with diabetes mellitus

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : E116-E122

John Wiley & Sons Inc

Access to resources Recommend Favorite

The real world experience of the biodegradable polymer‐coated sirolimus‐eluting coronary stent system

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : E93-E98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcomes of real‐world patients treated with an amphilimus polymer‐free stent versus new generation everolimus‐eluting stents

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1168-1176

John Wiley & Sons Inc

Access to resources Recommend Favorite